Applications from the field of Pharma & Biopharma from Shimadzu | LabRulez ICPMS

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Applications

| 2019 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of Residual Catalysts in Pharmaceuticals Using ICP Atomic Emission Spectrometry

Applications

| 2010 | Shimadzu

MP/ICP-AES

Instrumentation

MP/ICP-AES

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis by ICP Atomic Emission Spectrometry in Accordance with the ICH Q3D Guideline for Elemental Impurities Using ICPE-9820

Applications

| 2015 | Shimadzu

MP/ICP-AES

Instrumentation

MP/ICP-AES

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

High-Speed X-Ray Diffraction Analysis of Medicine Using OneSight Wide-Range High-Speed Detector

Applications

| 2015 | Shimadzu

XRD

Instrumentation

XRD

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Quantitative determination of heavy metals in ayurvedic tablets using ICP-MS

Posters

| 2017 | Shimadzu (ASMS)

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

ICH Q3D Elemental Impurities Analysis of Tablets by EDX - Verification Based on USP <233> ELEMENTAL IMPURITIES-PROCEDURES

Applications

| 2020 | Shimadzu

X-ray

Instrumentation

X-ray

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Applications

| 2023 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Applications

| 2022 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma from Shimadzu | LabRulez ICPMS

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Analysis of Residual Catalysts in Pharmaceuticals Using ICP Atomic Emission Spectrometry

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Analysis by ICP Atomic Emission Spectrometry in Accordance with the ICH Q3D Guideline for Elemental Impurities Using ICPE-9820

High-Speed X-Ray Diffraction Analysis of Medicine Using OneSight Wide-Range High-Speed Detector

Quantitative determination of heavy metals in ayurvedic tablets using ICP-MS

ICH Q3D Elemental Impurities Analysis of Tablets by EDX - Verification Based on USP <233> ELEMENTAL IMPURITIES-PROCEDURES

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances